Virpax Pharmaceuticals (VRPX) Stock Chart & Stock Price History $0.62 -0.04 (-6.09%) (As of 11/20/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Virpax Pharmaceuticals Stock Price Performance 5 Day Performance+0.46%1 Month Performance-9.24%3 Month Performance-48.58%6 Month Performance-20.19%Year-To-Date Performance-80.72%1 Year Performance-90.66% Receive VRPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! VRPX Stock Chart for Wednesday, November, 20, 2024 VRPX Chart by TradingView Virpax Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/20/2024$0.66$0.62-6.66%$0.71$0.58276,214 shs$3.02 million11/19/2024$0.70$0.66-5.44%$0.70$0.6541,217 shs$3.23 million11/18/2024$0.61$0.70+13.81%$0.72$0.62220,489 shs$3.42 million11/15/2024$0.64$0.61-4.72%$0.69$0.6180,506 shs$3.00 million11/14/2024$0.62$0.64+3.95%$0.65$0.59106,480 shs$3.15 million11/13/2024$0.62$0.62$0.65$0.55288,904 shs$3.03 million Get the Latest News and Ratings for VRPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024$0.67$0.62-7.45%$0.65$0.6256,941 shs$3.03 million11/11/2024$0.76$0.67-11.73%$0.74$0.6691,574 shs$3.28 million11/08/2024$0.76$0.76+0.20%$0.79$0.70105,769 shs$3.71 million11/07/2024$0.73$0.76+4.28%$0.76$0.7245,560 shs$3.70 million11/06/2024$0.69$0.73+4.96%$0.73$0.6988,823 shs$3.55 million11/05/2024$0.71$0.69-2.52%$0.73$0.6930,147 shs$3.38 million11/04/2024$0.73$0.71-2.32%$0.78$0.67204,739 shs$3.47 million11/01/2024$0.73$0.73-0.83%$0.76$0.6631,881 shs$3.56 million10/31/2024$0.72$0.73+1.95%$0.77$0.6784,557 shs$3.58 million10/30/2024$0.70$0.72+2.86%$0.72$0.6762,810 shs$3.51 million10/29/2024$0.72$0.70-2.92%$0.72$0.61118,604 shs$3.42 million10/28/2024$0.62$0.72+16.34%$0.72$0.59120,035 shs$3.52 million10/25/2024$0.62$0.62-0.19%$0.62$0.6031,810 shs$3.03 million10/24/2024$0.62$0.62-0.56%$0.63$0.5861,793 shs$3.03 million10/23/2024$0.64$0.62-2.90%$0.64$0.5884,453 shs$1.32 million10/22/2024$0.72$0.64-11.00%$0.72$0.62153,143 shs$1.35 million10/21/2024$0.68$0.72+6.15%$0.77$0.68301,569 shs$3.53 million Related Companies TLPH Stock Price Chart AWH Stock Price Chart IPA Stock Price Chart NKGN Stock Price Chart INDP Stock Price Chart TSBX Stock Price Chart PHXM Stock Price Chart KPRX Stock Price Chart MBIO Stock Price Chart IMNN Stock Price Chart Receive VRPX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRPX) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredThe smart-money is buying this US$1 lithium stockLithium is getting white-hot once again! And that means well-timed investors who position now in the best n...Resource Stock Digest | Sponsored31 Billionaires Are Loading Up on This SectorWhy are 31 of the world's richest billionaires, like Warren Buffett, Jeff Bezos, the Walton family, and Bill G...InvestorPlace | SponsoredFormer Trump advisor releases terrifying warningGoldman Sachs: 300 Million People Are At Risk The mainstream media are practically ignoring the most import...Wide Moat Research | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virpax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
